Skip to main content
Premium Trial:

Request an Annual Quote

Prolinx Taps VWR to Distribute RapXtract in North America

NEW YORK, Oct. 7 - Prolinx today said it has hired VWR International to distribute its RapXtract superparamagnetic separation technology and accessories in North America.


According to Prolinx, its RapXtract technology, which uses mass action to remove dye labeled precursors from nucleic acid-labeling reactions, allows labs to use minimum sample volumes when performing research such as whole genome analysis, SNP discovery, drug-discovery research, toxicology analysis, and pharmacogenomics.


Prolinx, based in Bothell, Wash., currently sells two product lines based on the technology: RapXtract dye terminator removal kits and RapXtract fluorescent nucleic acid-purification kits.


Click here for more information.

The Scan

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.

Survey Sees Genetic Literacy on the Rise, Though Further Education Needed

Survey participants appear to have higher genetic familiarity, knowledge, and skills compared to 2013, though 'room for improvement' remains, an AJHG paper finds.

Study Reveals Molecular, Clinical Features in Colorectal Cancer Cases Involving Multiple Primary Tumors

Researchers compare mismatch repair, microsatellite instability, and tumor mutation burden patterns in synchronous multiple- or single primary colorectal cancers.

FarGen Phase One Sequences Exomes of Nearly 500 From Faroe Islands

The analysis in the European Journal of Human Genetics finds few rare variants and limited geographic structure among Faroese individuals.